Clinical Trials Logo

Clinical Trial Summary

Yigansan was used in Ming dynasty by Xue Kai as a remedy for restlessness and agitation in children. We expect that the total YGTSS scores of Yigansan-treated subjects will be significantly reduced compared to that of placebo-treated subjects.


Clinical Trial Description

Tourette's disorder (TD) is a chronic, childhood-onset neuropsychiatric disorder. It is characterized by multiple motor and vocal tics, including involuntary or semivoluntary, sudden, brief, intermittent, repetitive movements or sounds. Yigansan was used in several clinical trials, like dementia, pervasive developmental disorder, schizophrenia and Huntington's disease, with good results. So the investigators choose Yigansan as a Chinese medicine formula in this study. After the participants signed the consent form, they have to stop taking any Chinese medicine or western medicine for treating Tourette's disorder for two weeks and then are randomly assigned to Yigansan group or placebo group. Our hypothesis is that Yigansan will be expected to improve motor tics and vocal tics, and YGTSS scores will decrease after 4-weeks treatments; secondary outcomes are measured by CGI-TS (Clinical Global Impression-Tourette Syndrome) scale and GTS-QOL (The Gilles de la Tourette syndrome-quality of life scale), and the investigators will also proceed the basic research of metabolomics and biochemistry(GOT、GPT、BUN、Creatinine、K+). In order to ensure the relationship of Tourette's disorder and allergic rhinitis, the investigators will detect IgE. Besides, the investigators will collect blood and urine from every child or adolescent when a participant visits our clinic at week 0 and week 4. In order to find these biomarkers related to TD, the investigators will use ELISA kits to detect and quantitate significantly changeable concentration of cytokines associated with YGTSS scores. In addition to specific cytokine targets, the investigators will also find these metabolites involved in TD between two groups before and after taking YGS. The serum and urine samples will be prepared and subjected to LC-MS/MS analysis. In summary of the experimental designs and expected results, the therapy and background information will be more clarified on the therapeutic efficacy and safety by Yigansan treatment for TD. Most importantly, this study will provide a kind of Chinese medicine formula to relieve such a disorder that most doctors feel difficult to treat. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03564132
Study type Interventional
Source China Medical University Hospital
Contact
Status Completed
Phase Phase 2
Start date June 16, 2018
Completion date August 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05370391 - Comprehensive Behavioral Intervention for Tics N/A
Completed NCT04007913 - Incorporating teleCBIT Into a Hospital-Based Tic Program N/A
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Completed NCT04498364 - Extinction Learning in Adults With Tourette Syndrome N/A
Recruiting NCT03844919 - TICS: Transcranial Magnetic Stimulation for Intervening in Children With Tourette's Syndrome (CIHR) N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT00231985 - Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder Phase 2
Recruiting NCT06050369 - Objective Characterizatoion of Repetitive Behaviors N/A
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Completed NCT03483493 - Online Remote Behavioural Intervention for Tics (ORBIT) N/A
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Withdrawn NCT04765085 - Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for Tics N/A
Completed NCT02676492 - A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders N/A
Recruiting NCT01860300 - Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus N/A
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00056420 - Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement N/A
Completed NCT04128397 - An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disorder N/A
Recruiting NCT05547854 - Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program N/A
Completed NCT05047705 - Investigating Distress Tolerance in Adults With Tourette Syndrome N/A
Completed NCT03239210 - Effects of Ondansetron in Obsessive-compulsive and Tic Disorders Phase 4